Литусова, Екатерина Михайловна. Степень метилирования интрона 1 гена SNCA в CD45+ клетках периферической крови при болезни Паркинсона: выпускная квалификационная работа магистра: направление 16.04.01 «Техническая физика» ; образовательная программа 16.04.01_13 «Медицинская физика» = Methylation status of SNCA-intron1 in CD45+ peripheral blood cells in Parkinson's disease / Е. М. Литусова; Санкт-Петербургский политехнический университет Петра Великого, Институт биомедицинских систем и биотехнологий ; научный руководитель Д. И. Богомаз ; научный руководитель А. К. Емельянов ; консультант по нормоконтролю В. П. Октябрьский. — Санкт-Петербург, 2020. — 1 файл (2,0 Мб). — Загл. с титул. экрана. — Доступ по паролю из сети Интернет (чтение). — Adobe Acrobat Reader 7.0. — <URL:http://elib.spbstu.ru/dl/3/2020/vr/vr20-1063.pdf>. — <URL:http://elib.spbstu.ru/dl/3/2020/vr/rev/vr20-1063-o.pdf>. — <URL:http://elib.spbstu.ru/dl/3/2020/vr/rev/vr20-1063-r.pdf>. — <URL:http://elib.spbstu.ru/dl/3/2020/vr/rev/vr20-1063-a.pdf>. — DOI 10.18720/SPBPU/3/2020/vr/vr20-1063. — Текст
| Period | Read | Copy | Open | Total | |||
|---|---|---|---|---|---|---|---|
| Year 2021 | Quarter 1 | February | 1 | 0 | 0 | 0 | 1 |
| March | 0 | 0 | 0 | 0 | 0 | ||
| Quarter 2 | April | 0 | 0 | 0 | 0 | 0 | |
| May | 0 | 0 | 0 | 0 | 0 | ||
| June | 0 | 0 | 0 | 0 | 0 | ||
| Quarter 3 | July | 0 | 0 | 0 | 0 | 0 | |
| August | 0 | 0 | 0 | 0 | 0 | ||
| September | 0 | 0 | 0 | 0 | 0 | ||
| Quarter 4 | October | 0 | 0 | 0 | 0 | 0 | |
| November | 0 | 0 | 0 | 0 | 0 | ||
| December | 0 | 0 | 0 | 0 | 0 | ||
| 2022 | Quarter 1 | January | 0 | 0 | 0 | 0 | 0 |
| February | 0 | 0 | 0 | 0 | 0 | ||
| March | 0 | 0 | 0 | 0 | 0 | ||
| Quarter 2 | April | 0 | 0 | 0 | 0 | 0 | |
| May | 0 | 0 | 0 | 0 | 0 | ||
| June | 0 | 0 | 0 | 0 | 0 | ||
| Quarter 3 | July | 0 | 0 | 0 | 0 | 0 | |
| August | 0 | 0 | 0 | 0 | 0 | ||
| September | 0 | 0 | 0 | 0 | 0 | ||
| Quarter 4 | October | 0 | 0 | 0 | 0 | 0 | |
| November | 0 | 0 | 0 | 0 | 0 | ||
| December | 0 | 0 | 0 | 0 | 0 | ||
| 2023 | Quarter 1 | January | 0 | 0 | 0 | 0 | 0 |
| February | 0 | 0 | 0 | 0 | 0 | ||
| March | 0 | 0 | 0 | 0 | 0 | ||
| Quarter 2 | April | 0 | 0 | 0 | 0 | 0 | |
| May | 0 | 0 | 0 | 0 | 0 | ||
| June | 0 | 0 | 0 | 0 | 0 | ||
| Quarter 3 | July | 0 | 0 | 0 | 0 | 0 | |
| August | 0 | 0 | 0 | 0 | 0 | ||
| September | 0 | 0 | 0 | 0 | 0 | ||
| Quarter 4 | October | 0 | 0 | 0 | 0 | 0 | |
| November | 0 | 0 | 0 | 0 | 0 | ||
| December | 0 | 0 | 0 | 0 | 0 | ||
| 2024 | Quarter 1 | January | 0 | 0 | 0 | 0 | 0 |
| February | 0 | 0 | 0 | 0 | 0 | ||
| March | 0 | 0 | 0 | 0 | 0 | ||
| Quarter 2 | April | 0 | 0 | 0 | 0 | 0 | |
| May | 0 | 0 | 0 | 0 | 0 | ||
| June | 0 | 0 | 0 | 0 | 0 | ||
| Quarter 3 | July | 0 | 0 | 0 | 0 | 0 | |
| August | 0 | 0 | 0 | 0 | 0 | ||
| September | 0 | 0 | 0 | 0 | 0 | ||
| Quarter 4 | October | 0 | 0 | 0 | 0 | 0 | |
| November | 0 | 0 | 0 | 0 | 0 | ||
| December | 0 | 0 | 0 | 0 | 0 | ||
| Year 2025 | Quarter 1 | January | 0 | 0 | 0 | 0 | 0 |
| February | 0 | 0 | 0 | 0 | 0 | ||
| March | 1 | 0 | 0 | 0 | 1 | ||
| Quarter 2 | April | 0 | 0 | 0 | 0 | 0 | |
| May | 0 | 0 | 0 | 0 | 0 | ||
| June | 0 | 0 | 0 | 0 | 0 | ||
| Quarter 3 | July | 0 | 0 | 0 | 0 | 0 | |
| Total | 2 | 0 | 0 | 0 | 2 | ||